Alpha Omega Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Alpha Omega Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-328	Closed	-$37K	–	567
2019 Q2	$37K	Buy	328 +14	+4%	+$1.64K	0.02%	285
2019 Q1	$39K	Hold	314	–	–	0.02%	271
2018 Q4	$32K	Hold	314	–	–	0.02%	252
2018 Q3	$40K	Hold	314	–	–	0.02%	246
2018 Q2	$34K	Buy	+314	New	+$34.2K	0.02%	258

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alpha Omega Wealth Management's ZBH Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Zimmer Biomet (ZBH) in Q3 2019, closing a stake of 328 shares — an estimated $37K sold.

Alpha Omega Wealth Management first reported a position in ZBH in Q2 2018 and held it in 5 quarters. The position peaked at $40K in Q3 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Alpha Omega Wealth Management reported no remaining Zimmer Biomet position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 328 Zimmer Biomet shares in Q3 2019, an estimated $37K.
Alpha Omega Wealth Management first reported a position in Zimmer Biomet in Q2 2018 and held it in 5 quarters.
Alpha Omega Wealth Management's Zimmer Biomet position peaked at $40K in Q3 2018.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.